Immuron Limited IMRN
$ 1.94
3.19%
Annual report 2022
added 09-09-2022
Country |
Australia |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
|
Employees in the company |
- |
Shares |
- |
Market Cap[1] |
$ 18.3 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.